Tecogen (TGEN) Insider John Albertine Buys $129K of Stock
John Albertine has purchased 25,000 shares of TGEN, signaling insider confidence.
Reviewed by automated data checks against the source filing. How we make and check alerts
John Albertine bought 25,000 shares of Tecogen Inc. ($TGEN) at an average price of $5.17, worth about $129,250, on June 26, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $TGEN is down 15.7% after 1 week, down 35.4% after 1 month and down 59.6% to date (from the $5.17 close on Jun 26, 2026).
Key Points
- John Albertine bought 25,000 shares of TGEN at an average price of $5.17, totaling about $129,250 on June 26, 2026.
- Shares of TGEN traded at $5.22 on Wednesday, with notable insider buying activity on the same day.
- Vanguard Capital Management opened a new position in TGEN with 769,964 shares, while other funds adjusted their holdings.
Get $TGEN trade alerts by text
We text you when insiders, Congress or big funds trade $TGEN. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Tecogen Inc. alert may contain errors. Disclosures
John Albertine made a significant move by purchasing 25,000 shares of TGEN on June 26, 2026. He bought these shares at an average price of $5.17, making the total purchase worth approximately $129,250. This transaction was not part of a planned trading program, which can indicate a personal vote of confidence in the company.
What Changed in John Albertine's TGEN Position
John Albertine's latest transaction reflects a new stake in TGEN, as there were no prior shares recorded under his name. This purchase aligns with other insider activities on the same day, suggesting a wave of confidence among the company's insiders.
Other Institutional Activity in TGEN
Vanguard Capital Management LLC opened a new position in TGEN, acquiring 769,964 shares valued at about $1.97 million. Bard Associates Inc slightly reduced its holdings by 798 shares, ending with 688,309 shares worth around $1.76 million, marking a 0.1% decrease. Clear Harbor Asset Management, LLC increased its stake by 40,000 shares to 650,000 shares, valued at approximately $1.66 million, reflecting a 6.6% increase. Portolan Capital Management, LLC trimmed its position by 2,255 shares, maintaining 443,555 shares worth about $1.14 million, a 0.5% decrease.
Tecogen Inc. Stock Up 67.3%
Shares of TGEN traded near $5.22 on Wednesday. The stock has experienced insider buying activity, which often attracts investor attention. However, detailed financial metrics like market cap and P/E ratio were not available.
Insider Buying and Selling at Tecogen Inc.
The recent insider activity at TGEN was notable on June 26, 2026. Multiple insiders, including Angelina Galiteva with 25,000 shares and CEO Abinand Rangesh with a total of 200,122 shares across two transactions, made purchases. Roger Deschenes, the CAO, and Stephen Lafaille, the VP of Business Development, each bought 29,013 shares. COO and President Robert Panora acquired 9,671 shares. None of these transactions were planned, indicating possible confidence in the company's future.
Analysts Set New Price Targets
On August 18, 2025, Roth Capital initiated coverage on TGEN with a 'buy' rating and a $15 price target. Earlier, on March 17, 2023, H.C. Wainwright reiterated its 'buy' rating with a $4.5 price target. These ratings suggest positive sentiment from analysts.
Bottom Line
John Albertine's purchase of TGEN shares, along with similar moves by other insiders, could signal confidence in the company's prospects. Such insider activity often catches the eye of investors looking for potential opportunities. However, it's important to remember that insider transactions can have various motivations and aren't always indicative of future performance.
Source: John Albertine's Form 4 filing on $TGEN (Jun 26, 2026). Find the original filing: TGEN Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts
